The website uses cookies that do not contain personal data and serve for the sole purpose of improving the user experience. Your presence on the website implies that you agree to the use of these cookies. For more details about personal data protection, please read the following link.
Issuer
Replek AD Skopje
Issuer's basic data
Address
Ul.Kozle 188
City
Skopje
State
Makedonija
Mail
info@replek.mk
Site
http://www.replek.mk/
Contact person +
Suzana Milosevska
Phone
+389 2 3081 343
Fax
/
Prospectus
Download Prospectus
Year 2021 2020 2019
Total Revenue from operation Activities 1,220,160 1,251,407 1,049,284
Operating profit 161,194 184,976 152,880
Net profit 134,793 163,714 133,930
Equity 1,560,519 1,527,870 1,472,185
Total liabilities 559,861 589,007 442,997
Total assets 2,120,379 2,116,877 1,915,182
Market capitalization 2,639,952 2,695,680 1,988,771
* data in 000 MKD
Methodology
Year 2021 2020 2019
Return on sales 13.21% 14.78% 14.57%
Net earnings per share (EPS) 5,200.34 6,316.11 5,167.06
Return on assets 6.36% 7.73% 6.99%
Return on equity 8.64% 10.72% 9.10%
Price to earnings 19.59 16.47 14.85
Book value per share 60,205.20 58,945.59 56,797.26
Price to Book Value 1.69 1.76 1.35
Dividend Per Share 3,412.00 4,168.00
Dividend yield 0.00% 3.28% 5.43%
Replek AD Skopje is a company that primarily operates in the production of pharmaceutical products, supply and wholesale of medicaments, medical consumable materials and medical equipment. The company's core business is development, design and production of generic medicines in different pharmaceutical therapeutic categories, as oral dosage forms: tablets, capsules and oral solutions, as well as medicines for topical use (creams, ointments, solutions), by the Replekpharm - pharmaceutical factory, a daughter company of the REPLEK AD. Additionally, the Company operates pharmacies, engaged in retail supply of pharmaceuticals; running department store Replek Hubo Market, which offers various household products and a club restaurant.

Managing Board
Dushan Pecovski - President and General manager
Biljana Nestorovska Gjosevska
Aleksandar Tomovski
Gelevski Pance
Kosta Koteski
Supervisory Board 
Antonio Georgievski - President
Petar Andreevski
Vladimir Gashevski
Naum Janakiev

  1. Non-trade transfers of listed companies' share
    According to the data from the Central Securities Depositary we inform that the following non-trade transfers of listed companies' shares were executed

  2. Block trade
    Block trade with shares of Replek AD Skopje

  3. Block trade
    Block trade with shares of Replek AD Skopje

  4. Non-trade transfers of listed companies' share
    According to the data from the Central Securities Depositary we inform that the following non-trade transfers of listed companies' shares were executed

  5. Block trade
    Block trade with shares of Replek AD Skopje

  6. Block trade
    Block trade with shares of Replek AD Skopje

  7. Block trade
    Block trade with shares of Replek AD Skopje

  8. Public auctions for big packages of shares
    Public auctions for big packages of shares

  9. Share buy-backs and non-trade transfers of listed companies' shares

    We inform you about executed share buy-backs and non-trade transfers of listed companies' shares

  10. Non-trade transfers of listed companies' share
    According to the data from the Central Securities Depositary we inform that the following non-trade transfers of listed companies' shares were executed
Symbols
Price movement
Volume
Symbol data
Market segment:
Exchange Listing - Ordinary shares
ISIN:
MKREPL101013
Total shares
25,920
Last trade: 8/4/2022
Max Price:
90,000.00
Min Price:
90,000.00
Avg Price:
90,000.00
Volume:
8
Value:
720,000
Trades:
2
Last 52 weeks
Max Price:
109,000.00
Min Price:
83,005.00
Volume:
715
Value:
72,413,274
Trades:
169

* the average price is from the last trading day

**data doesn't inculde block trades

*** the ordinary shares and the priority shares own by the Pension and Disability Insurance Fund of the Republic of Macedonia – PDIF (if they are issued) are summed up. The priority shares own by the PDIF are converted in ordinary shares at the moment of sale.

Historical Data